ORGANOVO HOLDINGS, INC.
ONVOOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $144,000 | $109,000 | $370,000 | $1.5M | $0 | $2.2M |
| Operating income | −$12.6M | −$15.1M | −$17.7M | −$11.5M | −$16.8M | −$21.5M |
| Net income | −$2.5M | −$14.7M | −$17.3M | −$11.4M | −$16.8M | −$18.7M |
| Total assets | $14.7M | $6.3M | $20.3M | $33.3M | $39.9M | $28.4M |
| Total liabilities | $4.2M | $2.7M | $5.0M | $3.1M | $721,000 | $1.8M |
| Equity | $10.5M | $3.6M | $15.3M | $30.2M | $39.2M | $26.6M |
| EPS (diluted) | $-1.70 | $-19.25 | $-1.98 | $-1.32 | — | — |
| Shares out. | 2.6M | 14.4M | 8.7M | 8.7M | 8.7M | 130.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −8761.1%
- Net margin
- −1727.8%
- Return on equity
- −23.7%
- Return on assets
- −17.0%
- Return on capital (ROCE)
- −115.6%
- Liabilities / assets
- 28.4%
- Debt / equity
- 0.40×
- Book value / share
- $4.04
- Revenue growth (YoY)
- 32.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -75.52distress
- Accruals / assets
- 47.6%high accruals
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Feb 14, 2025
- NT 10-Kmissed a reporting deadline ↗Jun 29, 2023
- NT 10-Kmissed a reporting deadline ↗Sep 28, 2011
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Esousa Group Holdings LlcPassive (13G)Apr 6, 2026
- Armistice Capital, LlcPassive (13G)May 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Cohen Douglas JayDirector | Jan 27, 2026 | Grant | 15,000 | $0.00 |
| Murphy KeithOfficer — EXECUTIVE CHAIRMAN | Jan 27, 2026 | Grant | 15,000 | $0.00 |
| Milhous Alison TjosvoldDirector | Jan 27, 2026 | Grant | 15,000 | $0.00 |
| Gobel DavidDirector | Jan 27, 2026 | Grant | 15,000 | $0.00 |
| Stern Adam KDirector | Jan 27, 2026 | Grant | 15,000 | $0.00 |
| Gobel DavidDirector | Nov 17, 2025 | Sell | 3,266 | $2.24 |
| Gobel DavidDirector | Aug 7, 2024 | Grant | 19,607 | $0.00 |
| Cohen Douglas JayDirector | Aug 7, 2024 | Grant | 19,607 | $0.00 |
| Milhous Alison TjosvoldDirector | Aug 7, 2024 | Grant | 19,607 | $0.00 |
| Stern Adam KDirector | Aug 7, 2024 | Grant | 19,607 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Apr 15, 2025 | 198,490 | 1.0 | +170.5% |
| Mar 31, 2025 | 73,382 | 1.0 | -89.1% |
| Mar 14, 2025 | 674,740 | 1.0 | -50.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Other material eventApr 3, 2026
- Shareholder voteDec 18, 2025
- Director / officer change · Regulation FD disclosureAug 14, 2025
- Other material eventMay 6, 2025
- Amended charter or bylaws · Regulation FD disclosure · Other material eventApr 24, 2025
- Regulation FD disclosureApr 23, 2025
- Results of operations · Regulation FD disclosure · Other material eventApr 2, 2025
- Regulation FD disclosureMar 27, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13GApr 6, 2026
- 8-KApr 3, 2026
- 424B4PROSPECTUSApr 2, 2026
- EFFECTMar 31, 2026
- CORRESPMar 31, 2026
- CORRESPMar 31, 2026
- S-1/AAMENDMENT NO. 1 TO FORM S-1Mar 31, 2026
- CORRESPMar 30, 2026
- CORRESPMar 30, 2026
- CORRESPMar 27, 2026
- CORRESPMar 27, 2026
- S-1REGISTRATION STATEMENTMar 27, 2026
- UPLOADMar 13, 2026
- DRSMar 9, 2026
- 10-QFeb 11, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.